Mesa Laboratories (NASDAQ:MLAB) PT Raised to $160.00
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) had its price objective raised by research analysts at Evercore ISI from $120.00 to $160.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s target price would indicate a potential upside of 20.92% […]
More Stories
Q3 2024 EPS Estimates for Valero Energy Co. Lowered by Analyst (NYSE:VLO)
Valero Energy Co. (NYSE:VLO – Free Report) – Research analysts at Zacks Research dropped their Q3 2024 earnings per share...
Raymond James Weighs in on Osisko Gold Royalties Ltd’s Q3 2024 Earnings (TSE:OR)
Osisko Gold Royalties Ltd (TSE:OR – Free Report) – Equities researchers at Raymond James cut their Q3 2024 earnings per...
Xinyuan Real Estate (NYSE:XIN) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Xinyuan Real Estate (NYSE:XIN – Free Report) in a report published on Tuesday. The...
ARC Document Solutions (NYSE:ARC) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of ARC Document Solutions (NYSE:ARC – Free Report) in a report released on Tuesday morning....
Moody’s (NYSE:MCO) Downgraded by StockNews.com
StockNews.com lowered shares of Moody’s (NYSE:MCO – Free Report) from a buy rating to a hold rating in a research...
Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report issued on Tuesday. The brokerage...